Last updated: 11 September 2024 at 4:15pm EST

Susanna Gatti High M.B.A. Net Worth




The estimated Net Worth of Susanna Gatti High is at least $13 Million dollars as of 11 September 2024. Ms High owns over 5,270 units of Dyne Therapeutics stock worth over $4,583,951 and over the last 8 years she sold DYN stock worth over $8,032,641. In addition, she makes $409,310 as Chief Operating Officer at Dyne Therapeutics.

Ms A DYN stock SEC Form 4 insiders trading

Ms has made over 23 trades of the Dyne Therapeutics stock since 2017, according to the Form 4 filled with the SEC. Most recently she sold 5,270 units of DYN stock worth $168,060 on 11 September 2024.

The largest trade she's ever made was selling 85,270 units of Dyne Therapeutics stock on 10 June 2024 worth over $2,583,681. On average, Ms trades about 7,790 units every 75 days since 2016. As of 11 September 2024 she still owns at least 140,612 units of Dyne Therapeutics stock.

You can see the complete history of Ms High stock trades at the bottom of the page.





Ms. Susanna Gatti High M.B.A. biography

Susanna Gatti High M.B.A. is the Chief Operating Officer at Dyne Therapeutics.

What is the salary of Ms A?

As the Chief Operating Officer of Dyne Therapeutics, the total compensation of Ms A at Dyne Therapeutics is $409,310. There are 4 executives at Dyne Therapeutics getting paid more, with Dewei Qiao having the highest compensation of $2,036,560.



How old is Ms A?

Ms A is 53, she's been the Chief Operating Officer of Dyne Therapeutics since . There are 7 older and 15 younger executives at Dyne Therapeutics. The oldest executive at Dyne Therapeutics, Inc. is Yuezhou Ou, 68, who is the Independent Non-Executive Director.

What's Ms A's mailing address?

Susanna's mailing address filed with the SEC is C/O DYNE THERAPEUTICS, INC., 1560 TRAPELO ROAD, WALTHAM, MA, 02451.

Insiders trading at Dyne Therapeutics

Over the last 4 years, insiders at Dyne Therapeutics have traded over $197,573,300 worth of Dyne Therapeutics stock and bought 5,790,447 units worth $92,382,301 . The most active insiders traders include Capital Management, L.P.Kol..., Jason P Rhodes, and Dirk Kersten. On average, Dyne Therapeutics executives and independent directors trade stock every 12 days with the average trade being worth of $3,566,016. The most recent stock trade was executed by Oxana Beskrovnaya on 11 September 2024, trading 2,161 units of DYN stock currently worth $68,914.



What does Dyne Therapeutics do?

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..



What does Dyne Therapeutics's logo look like?

Dyne Therapeutics, Inc. logo

Complete history of Ms High stock trades at Bluebird bio Inc and Dyne Therapeutics

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
11 Sep 2024 Susanna Gatti High
Chief Operating Officer
Sale 5,270 $31.89 $168,060
11 Sep 2024
140,612
19 Aug 2024 Susanna Gatti High
Chief Operating Officer
Sale 2,910 $45.12 $131,299
19 Aug 2024
145,882
21 Jun 2024 Susanna Gatti High
Chief Operating Officer
Option 39,950 $5.54 $221,323
21 Jun 2024
158,955
12 Jun 2024 Susanna Gatti High
Chief Operating Officer
Option 40,000 $5.54 $221,600
12 Jun 2024
188,792
10 Jun 2024 Susanna Gatti High
Chief Operating Officer
Sale 85,270 $30.30 $2,583,681
10 Jun 2024
148,792
16 May 2024 Susanna Gatti High
Chief Operating Officer
Sale 2,738 $28.27 $77,403
16 May 2024
154,062
8 Mar 2024 Susanna Gatti High
Chief Operating Officer
Sale 29,491 $26.59 $784,166
8 Mar 2024
156,800
7 Mar 2024 Susanna Gatti High
Chief Operating Officer
Sale 1,591 $25.85 $41,127
7 Mar 2024
186,291
11 Dec 2023 Susanna Gatti High
Chief Operating Officer
Sale 1,616 $10.72 $17,324
11 Dec 2023
187,882
2 Nov 2023 Susanna Gatti High
Chief Operating Officer
Sale 9,939 $7.40 $73,549
2 Nov 2023
94,605
18 Sep 2023 Susanna Gatti High
Chief Operating Officer
Sale 2,672 $9.41 $25,144
18 Sep 2023
104,544
12 Sep 2023 Susanna Gatti High
Chief Operating Officer
Sale 1,635 $10.41 $17,020
12 Sep 2023
107,216
13 Jun 2023 Susanna Gatti High
Chief Operating Officer
Sale 1,625 $12.43 $20,199
13 Jun 2023
108,851
14 Mar 2023 Susanna Gatti High
Chief Operating Officer
Sale 1,559 $13.33 $20,781
14 Mar 2023
110,476
9 Dec 2022 Susanna Gatti High
Chief Operating Officer
Sale 751 $10.87 $8,163
9 Dec 2022
112,035
11 Mar 2022 Susanna Gatti High
Chief Operating Officer
Sale 765 $8.73 $6,678
11 Mar 2022
73,003
23 Sep 2021 Susanna Gatti High
Chief Operating Officer
Sale 2,451 $17.22 $42,206
23 Sep 2021
33,453
6 Dec 2018 Susanna Gatti High
Chief Operating Officer
Sale 1,875 $105.71 $198,206
6 Dec 2018
13,735
3 Dec 2018 Susanna Gatti High
Chief Operating Officer
Sale 1,890 $113.83 $215,139
3 Dec 2018
15,610
4 Jun 2018 Susanna Gatti High
Chief Operating Officer
Option 3,500 $68.65 $240,275
4 Jun 2018
21,000
28 Feb 2018 Susanna Gatti High
Chief Operating Officer
Option 1,044 $68.65 $71,671
28 Feb 2018
18,544
30 Jan 2018 Susanna Gatti High
Chief Operating Officer
Sale 17,262 $195.91 $3,381,798
30 Jan 2018
11,250
1 Dec 2017 Susanna Gatti High
Chief Operating Officer
Sale 1,282 $172.15 $220,696
1 Dec 2017
13,718


Dyne Therapeutics executives and stock owners

Dyne Therapeutics executives and other stock owners filed with the SEC include: